Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

Most of Haleon's top line was supported by a mixture of price hikes, and to a smaller extent, a better volume and product mix. Combined with the firm's efficiency and productivity initiatives ...

British consumer healthcare group Haleon on Tuesday said it gained full control of its Chinese joint venture after acquiring ...

GSK’s consumer health spinout Haleon has acquired exclusive US rights to commercialise the gel-based product, called MED3000, in return for an initial upfront payment of $4 million, milestone ...

There’s a strong valuation case for doing so. Haleon to invest $54 mln in US R&D centre to boost product innovation Consumer healthcare company Haleon said on Wednesday it will invest $54 ...